Browsing by Subject "autoimmune haemolytic anaemia"
Now showing items 1-1 of 1
-
A multi-centre retrospective study of rituximab use in the treatment of relapsed or resistant warm autoimmune haemolytic anaemia
(Wiley-Blackwell, 2013-08-02)This retrospective analysis assessed the response, safety and duration of response to standard dose rituximab 375 mg/m(2) weekly for four weeks as therapy for patients with primary or secondary warm autoimmune haemolytic ...